1.

Seroprevalence of Dengue Antibodies among Healthy Blood Donors from Sabah, Malaysian Borneo: Blood Safety in Dengue-Endemic Communities

1.

Hepatitis E virus seroprevalence in pets in the Netherlands and the permissiveness of canine liver cells to the infection

2.

Hepatitis E virus seroprevalence in pets in the Netherlands and the permissiveness of canine liver cells to the infection

3.

Hepatitis E virus seroprevalence in pets in the Netherlands and the permissiveness of canine liver cells to the infection

1.

Seroprevalence of Toxoplasma gondii and immune responses in Belgian sheep

1.

High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium

2.

High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium

3.

High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium

1.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium

1.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

2.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

3.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

4.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

5.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

1.

Dutch Q fever epidemic in a ‘One Health’ context: outbreaks, seroprevalence and occupational risks

2.

Dutch Q fever epidemic in a ‘One Health’ context: outbreaks, seroprevalence and occupational risks

3.

Dutch Q fever epidemic in a ‘One Health’ context: outbreaks, seroprevalence and occupational risks

1.

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

2.

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

3.

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

4.

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

5.

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

1.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.

2.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.

3.

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.

1.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

2.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

3.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

4.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

5.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

6.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools

7.

SARS-CoV-2 Antibody Seroprevalence in Children and Workers from Belgian French-Speaking Primary Schools